The Partnership between the UAB Comprehensive Cancer Center (CCC), Tuskegee University (TU), and Morehouse School of Medicine (MSM) presents a unique opportunity to build on our successful accomplishments in training and education of the pipeline of future cancer research scientists, with emphasis on underrepresented racial/ethnic minorities. For this U54 application, we propose a seamless integration of our cancer education programs by focusing on ?hard? (structured courses/training developed through previous U54 funding) and ?soft? skills (e.g., career development roadmap, interviewing skills) needed to facilitate movement through our pipeline into the cancer research continuum, with the goal of having a diverse workforce well-prepared to address cancer health disparities and ?meet the nation's biomedical, behavioral, and clinical research needs,? as outlined in the RFA. This will be accomplished through the following specific aims: (1) To develop and implement an integrated cancer research education program that links underrepresented undergraduate and graduate/medical students with post-doctoral fellows, medical residents, junior faculty investigators, and senior level researchers through four integrated programs: (a) the Cancer Research Immersion Student Program (CRISP) for undergraduate students; (b) the Summer Cancer Research Education Program (SCREP) and Cancer Research Certificate Program (CRCP) for graduate and medical students; (c) the Health Disparities Research Education Program (HDREP) for postdoctoral fellows and medical residents as well as integration of undergraduate/graduate/medical students, postdoctoral fellows, and junior faculty into multidisciplinary research teams; and (d) the Transitional Pathway Program (TPP) that will facilitate the movement of undergraduate to graduate students, graduate/medical students to residents, postdoctoral fellows and/or junior faculty, and junior faculty to established researchers in cancer disparities. (2) To link cancer research scholars (undergraduate and graduate/medical students, medical residents, post- doctoral fellows, and junior faculty) with the Outreach Core to share their research findings with community members and obtain community feedback (e.g., Cancer Info Cafs) and to develop publications and communications for lay audiences (e.g., blogs or posts on social media, YouTube videos, policy briefs); and (3) To implement a mixed-method, triangulated evaluation of CRISP, SCREP, CRCP, HDREP, and TPP.
In this U54 Partnership application, we propose a seamless integration of our Research Education Core programs by focusing on both ?hard? (structured courses/experiences developed through previous funding cycles) and ?soft? skills (e.g., career advancement roadmap, interviewing skills) needed to facilitate movement through our pipeline in the cancer research continuum, with the goal of having a diverse workforce well- prepared to address cancer health disparities and ?meet the nation's biomedical, behavioral, and clinical research needs,? as outlined in the RFA.
|Akintobi, Tabia Henry; Lockamy, Elise; Goodin, Lisa et al. (2018) Processes and Outcomes of a Community-Based Participatory Research-Driven Health Needs Assessment: A Tool for Moving Health Disparity Reporting to Evidence-Based Action. Prog Community Health Partnersh 12:139-147|
|Angajala, Anusha; Mothershed, Essynce; Davis, Melissa B et al. (2018) Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer. Transl Oncol 12:493-501|
|Davis, Melissa; Tripathi, Shweta; Hughley, Raymond et al. (2018) AR negative triple negative or ""quadruple negative"" breast cancers in African American women have an enriched basal and immune signature. PLoS One 13:e0196909|
|Angajala, Anusha; Lim, Sangbin; Phillips, Joshua B et al. (2018) Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism. Front Immunol 9:1605|
|Abisoye-Ogunniyan, Abisola; Lin, Huxian; Ghebremedhin, Anghesom et al. (2018) Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c. Cancer Lett 431:1-10|
|Mukherjee, Angana; Hollern, Daniel P; Williams, Oluwasina G et al. (2018) A Review of FOXI3 Regulation of Development and Possible Roles in Cancer Progression and Metastasis. Front Cell Dev Biol 6:69|
|Ahmed, Md Shakir Uddin; Salam, Ahmad Bin; Yates, Clayton et al. (2017) Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer. Int J Nanomedicine 12:6973-6984|
|Williams, Samuel K; Braxton, Joanne M; Gosdin, Melissa et al. (2017) Evidence-Based Care for the Elderly: Uses of ""the Grandmother Principle"". J Health Care Poor Underserved 28:7|
|Gao, Song; Wang, Yicun; Wang, Meng et al. (2017) MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 8:41451-41464|
|Zhang, Yifan; Li, Bingjin; Zhang, Xingyi et al. (2017) CD24 is a genetic modifier for risk and progression of prostate cancer. Mol Carcinog 56:641-650|
Showing the most recent 10 out of 141 publications